Single-electrode EEG-guided Binaural Beats for Attention and Well-being in Healthy Adults
EEG-Guided Binaural Beat Audio
+ Sham Control
Basic Science Study
Summary
Study start date: August 16, 2024
Actual date on which the first participant was enrolled.The study is exploring whether a new method of using binaural beats can help guide brain activity to promote relaxation and improve focus in healthy adults. Binaural beats are special audio tones that can potentially influence brain states, but they sometimes lead to discomfort or are not very effective when used in a static manner. This research aims to utilize real-time brain activity feedback recorded by a single-electrode EEG to dynamically adjust the binaural beats, potentially leading to a more effective and comfortable experience. The goal is to see if this method can help the brain reach and maintain a relaxed state, known as the low-alpha state, and whether this can improve attention, memory, and overall well-being. Participants in the study will listen to binaural beats while their brain activity is monitored using EEG, which is a technique that records the brain's electrical activity. The beats will be adjusted based on their brain waves to try to guide them into a low-alpha state, linked with relaxation and calmness, for up to 15 minutes. The study will measure whether this method improves subjective feelings of relaxation and focus, as well as objective performance on tasks that test attention, memory, and reaction times. There is a possibility that the dynamic adjustment of the beats might reduce discomfort and enhance the effectiveness of binaural beats in achieving the desired brain state.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.25 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Basic Science Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
ExperimentalGroup II
ShamStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Texas Tech University Health Sciences Center, Lubbock, TX, USA
Lubbock, United StatesOpen Texas Tech University Health Sciences Center, Lubbock, TX, USA in Google Maps